Large-scale delivery of seasonal malaria chemoprevention to children under 10 in Senegal: an economic analysis

by Catherine Pitt, Mouhamed Ndiaye, Lesong Conteh et al.
Health Policy Plan – Published: 24 July 2017

11 pp. 389 kB
https://academic.oup.com/heapol/article-
pdf/doi/10.1093/heapol/czx084/19242838/czx084.pdf

Seasonal Malaria Chemoprevention (SMC) is recommended for children under 5 in the Sahel and sub-Sahel. The burden in older children may justify extending the age range, as has been done effectively in Senegal. The financial costs of providing SMC for children under ten represent 12% of combined government and international spending on malaria in Senegal and 1.2% of Senegal’s general government expenditure on health per capita, making SMC potentially affordable especially if it were to avert substantial curative care costs.

(Visited 8 times, 1 visits today)
This entry was posted in Essential Medicines, General, Malaria. Bookmark the permalink.